文献速递腹部MR

肝细胞癌手术切除后复发检测:非增强肝脏MRI联合扩散加权成像与钆塞酸二钠增强MRI的对比

Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging.
PubMed 文献 · Br J Radiol · 2018-07-05

回顾性分析483例肝细胞癌切除术后接受肝脏MRI监测的患者,比较非增强MRI组与钆塞酸二钠增强全MRI组对复发肝细胞癌的诊断效能。非增强MRI灵敏度与准确率均较高,但全MRI组在总体患者中灵敏度(99.1% vs 94.7%)与准确率(99.2% vs 97.5%)显著更高;术后随访≥1年的患者中两组诊断效能无显著差异。

要点

  • 非增强MRI(含DWI)对复发肝细胞癌灵敏度达94.7%,全MRI达99.1%,两者准确率分别为97.5%与99.2%。
  • 术后随访≥1年的患者中,非增强MRI与钆塞酸二钠增强全MRI诊断效能无显著差异。
  • 非增强MRI可能作为术后随访的替代方法,至少适用于术后≥1年、复发风险相对较低的选择性患者。

核心结论

  • 非增强MRI可能作为替代随访方法,至少可在术后随访≥1年、复发风险相对较低的选择性患者中替代全MRI。

研究设计与样本

  • 回顾性研究,分析483例肝细胞癌切除术后接受肝脏MRI监测的患者(中位时间间隔7.7个月),由两名观察者独立分析非增强MRI组(T1加权、T2加权及扩散加权成像)与全MRI组(钆塞酸二钠增强加非增强MRI),采用受试者工作特征分析(含个体观察与共识)检测复发肝细胞癌。

诊断标准与关键数值

  • 首次随访MRI共113例患者检出197个复发肝细胞癌;基于患者分析,非增强MRI组灵敏度94.7%、全MRI组99.1%(p=0.025),准确率分别为97.5%与99.2%(p=0.021);术后随访≥1年患者中两组诊断效能无显著差异(p>0.05)。

临床应用与阅片要点

  • 术后随访≥1年、复发风险相对较低的选择性患者中,非增强MRI(含DWI)与钆塞酸二钠增强全MRI诊断效能相当;总体患者中非增强MRI灵敏度与准确率仍低于全MRI。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE:: To compare the diagnostic performance of non-contrast liver MRI to whole MRI using gadoxetic acid for detection of recurrent hepatocellular carcinoma (HCC) after hepatectomy.

METHODS:: This retrospective study analyzed 483 patients who underwent surveillance with liver MRI after hepatectomy for HCC (median time interval, 7.7 months). Non-contrast MRI set (T1- and T2 weighted and diffusion-weighted images) and whole MRI set (gadoxetic acid-enhanced and non-contrast MRI) were analyzed independently by two observers. Receiver operating characteristic analysis was used (with the observers' individual observations and consensus) to detect recurrent HCC. The accuracy, sensitivity, and specificity were calculated.

RESULTS:: A total of 113 patients had 197 recurrent HCCs on first follow-up MRI. Although non-contrast MRI had fairly high sensitivity for recurrent HCC, there were significant differences in sensitivity (94.7% vs 99.1%, p = 0.025) and accuracy (97.5% vs 99.2%, p = 0.021) between the two image sets (per-patients base analysis). However, in patients followed for ≥1 year after surgery, the diagnostic performance of non-contrast MRI and whole MRI were not significantly different (p > 0.05).

CONCLUSION:: Non-contrast MRI may serve as an alternative follow-up method which can potentially replace whole MRI at least in selected patients followed up ≥1 year after surgery who have relatively lower risk of HCC recurrence.

ADVANCES IN KNOWLEDGE:: There is no consensus regarding the ideal imaging modality or follow-up interval after resection of HCC. Non-contrast MRI had comparable performance to that of gadoxetic acid-enhanced MRI in the detection of HCC recurrence during surveillance ≥1 year after surgery.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Min JH, Kim YK, Choi SY, et al. Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging. Br J Radiol. 2018. PMID: 29927634. doi:10.1259/bjr.20180177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。